Testosterone Reference Ranges in Normally Cycling Healthy Premenopausal Women

被引:57
作者
Braunstein, Glenn D. [1 ]
Reitz, Richard E. [2 ]
Buch, Akshay [3 ]
Schnell, Dan [4 ]
Caulfield, Michael P. [2 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Quest Diagnost Inc, San Juan Capistrano, CA USA
[3] Warner Chilcott Pharmaceut Inc, Mason, OH USA
[4] Procter & Gamble Inc, Mason, OH USA
关键词
Testosterone; Reference Ranges; Premenopausal Women; Sex Hormone Binding Globulin; SURGICALLY MENOPAUSAL WOMEN; SEXUAL DESIRE DISORDER; PLACEBO-CONTROLLED TRIAL; SERUM ANDROGEN LEVELS; MASS-SPECTROMETRY; CIRCULATING ANDROGENS; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; REPRODUCTIVE-AGE; MENSTRUAL-CYCLE;
D O I
10.1111/j.1743-6109.2011.02380.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. At present, there are no well-accepted reference ranges for serum testosterone concentrations in women. Aim. The aim of this study was to determine the reference ranges for serum testosterone and sex hormone-binding globulin (SHBG) in premenopausal women with normal menstrual cycles. Methods. We measured serum total, free, and bioavailable testosterone and SHBG concentrations in 161 healthy, normally cycling women (18-49 years). Morning blood samples were collected during follicular, mid-cycle, and luteal phases of the menstrual cycle and analyzed using validated methods. Mean, median, and weighted average hormone levels across menstrual cycle phases as well as percentiles for a typical 30-year-old woman were determined. Main Outcome Measures. Age-related serum levels of total, free, and bioavailable testosterone and SHBG levels in normally cycling premenopausal women. Results. Serum testosterone concentrations exhibited an age-related decline, whereas SHBG remained relatively stable across studied age ranges. Reference ranges for total, free, and bioavailable testosterone and SHBG were established using 5th and 95th percentiles. The estimated 5th and 95th percentiles for a 30-year-old woman were: testosterone, 15-46 ng/dL (520-1595 pmol/L); free testosterone, 1.2-6.4 pg/mL (4.16-22.2 pmol/L); calculated free testosterone, 1.3-5.6 pg/mL (4.5-19.4 pmol/L); bioavailable testosterone, 1.12-7.62 ng/dL (38.8-264.21 pmol/L); and SHBG 18-86 nmol/L. The variations of hormones and SHBG across menstrual cycle were consistent with previous literature. Conclusions. Reference ranges for free, total, and bioavailable testosterone and SHBG were established in premenopausal women using validated immunoassays and an adequate number of subjects consistent with recommendations by the National Committee for Clinical Laboratory Standards. The increase in testosterone in the mid-cycle period is relatively small compared with the overall variability, so these reference ranges can be applied irrespective of the day in the menstrual cycle the sample has been taken. Braunstein GD, Reitz RE, Buch A, Schnell D, and Caulfield MP. Testosterone reference ranges in normally cycling healthy premenopausal women. J Sex Med 2011;8:2924-2934.
引用
收藏
页码:2924 / 2934
页数:11
相关论文
共 46 条
[1]   Dehydroepiandrosterone replacement in women with adrenal insufficiency [J].
Arlt, W ;
Callies, F ;
van Vlijmen, JC ;
Koehler, I ;
Reincke, M ;
Bidlingmaier, M ;
Huebler, D ;
Oettel, M ;
Ernst, M ;
Schulte, HM ;
Allolio, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1013-1020
[2]   Measurement of total serum testosterone levels using commercially available kits: High degree of between-kit variability [J].
Boots, LR ;
Potter, S ;
Potter, HD ;
Azziz, R .
FERTILITY AND STERILITY, 1998, 69 (02) :286-292
[3]   Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women - A randomized, placebo-controlled trial [J].
Braunstein, GD ;
Sundwall, DA ;
Katz, M ;
Shifren, JL ;
Buster, JE ;
Simon, JA ;
Bachman, G ;
Aguirre, OA ;
Lucas, JD ;
Rodenberg, C ;
Buch, A ;
Watts, NB .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) :1582-1589
[4]  
Braunstein GD, 2002, FERTIL STERIL, V77, pS94
[5]   Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial [J].
Buster, JE ;
Kingsberg, SA ;
Aguirre, O ;
Brovm, C ;
Breaux, JG ;
Buch, A ;
Rodenberg, CA ;
Wekselman, K ;
Casson, P .
OBSTETRICS AND GYNECOLOGY, 2005, 105 (05) :944-952
[6]   Androgen replacement therapy in women [J].
Cameron, DR ;
Braunstein, GD .
FERTILITY AND STERILITY, 2004, 82 (02) :273-289
[7]   Determinants of serum total and free testosterone levels in women over the age of 65 years [J].
Cappola, Anne R. ;
Ratcliffe, Sarah J. ;
Bhasin, Shalender ;
Blackman, Marc R. ;
Cauley, Jane ;
Robbins, John ;
Zmuda, Joseph M. ;
Harris, Tamara ;
Fried, Linda P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :509-516
[8]   Circulating androgen levels and self-reported sexual function in women [J].
Davis, SR ;
Davison, SL ;
Donath, S ;
Bell, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01) :91-96
[9]   Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen [J].
Davis, Susan R. ;
Moreau, Michele ;
Kroll, Robin ;
Bouchard, Celine ;
Panay, Nick ;
Gass, Margery ;
Braunstein, Glenn D. ;
Hirschberg, Angelica Linden ;
Rodenberg, Cynthia ;
Pack, Simon ;
Koch, Helga ;
Moufarege, Alain ;
Studd, John .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :2005-2017
[10]   Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial [J].
Davis, Susan R. ;
van der Mooren, M. J. ;
van Lunsen, Rik H. W. ;
Lopes, Patrice ;
Ribot, Jean ;
Rees, Margaret ;
Moufarege, Alain ;
Rodenberg, Cynthia ;
Buch, Akshay ;
Purdie, David W. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (03) :387-396